Clinical Trial 55613

Berlin, NJ 08009


A phase 2/3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults with ADHD to assess to efficacy and safety.

Qualified Participants Must:

• Be 18 - 55 years old
• Have a diagnosis of ADHD
• Additional eligibility criteria apply

Qualified Participants May Receive:

Up to $750 for time and tavel-related expenses

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.